ChemicalBook > CAS DataBase List > Sitagliptin N-Phoshate IMpurity

Sitagliptin N-Phoshate IMpurity

Product Name
Sitagliptin N-Phoshate IMpurity
CAS No.
1351498-25-3
Chemical Name
Sitagliptin N-Phoshate IMpurity
Synonyms
Sitagliptin Impurity 33;Sitagliptin N-Phoshate IMpurity;(R)-(4-oxo-4-(3-(trifluoromethyl);Phosphoramidic acid, N-[3-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-oxo-1-[(2,4,5-trifluorophenyl)methyl]propyl]-;(R)-(4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)phosphoramidic acid? (Sitagliptin Impurity）
CBNumber
CB72675706
Molecular Formula
C16H16F6N5O4P
Formula Weight
487.29
MOL File
1351498-25-3.mol
More
Less

Sitagliptin N-Phoshate IMpurity Property

Boiling point:
681.2±65.0 °C(Predicted)
Density 
1.78±0.1 g/cm3(Predicted)
pka
2.22±0.10(Predicted)
More
Less

Hazard and Precautionary Statements (GHS)

Sitagliptin N-Phoshate IMpurity Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Sitagliptin N-Phoshate IMpurity Suppliers

China 16 India 1 United States 3 Global 20
BOC Sciences
Tel
1-631-485-4226; 16314854226
Email
info@bocsci.com
Country
United States
ProdList
14055
Advantage
65
BOC Sciences
Tel
16314854226
Email
info@bocsci.com
Country
United States
ProdList
9923
Advantage
65
Standardpharm Co. Ltd.
Tel
86-714-3992388
Email
overseasales1@yongstandards.com
Country
United States
ProdList
14332
Advantage
58

1351498-25-3, Sitagliptin N-Phoshate IMpurityRelated Search:

Duloxetine N-DesMethyl Metabolite N'-[(2Z)-Piperazin-2-ylidene]trifluoroacetohydrazide Sitagliptin impurity H HCl (R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione Methyl 3-Oxo-4-(2,4,5-trifluorophenyl)butanoate Sitagliptin Impurity 26 Benzenebutanoicacid,b-aMino-2,4,5-trifluoro-,Methylester,(bR)- Sitagliptin Impurity 14 Sitagliptin Impurity 34 Sitagliptin Impurity 31 4-[3-(Methylamino)-1-(2-thienyl)propyl]- Sitagliptin phosphate 3-THIOPHENEPROPANAMINE, N,N-DIMETHYL-GAMMA-(1-NAPHTHALENYLOXY)-, ETHANEDIOATE(1:1) (2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one Sitagliptin Defuoro IMpurity 3 (S)-Sitagliptin Phosphate 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride Sitagliptin DeaMino IMpurity 1

  • Sitagliptin Impurity 33
  • Sitagliptin N-Phoshate IMpurity
  • (R)-(4-oxo-4-(3-(trifluoromethyl)
  • Phosphoramidic acid, N-[3-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-oxo-1-[(2,4,5-trifluorophenyl)methyl]propyl]-
  • (R)-(4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)phosphoramidic acid? (Sitagliptin Impurity）
  • 1351498-25-3
  • C16H16F6N5O4P